Abstract
Eight difluoroboron complexes of curcumin derivatives carrying alkyne groups containing substituents have been synthesized following an optimised reaction pathway. The complexes were received in yields up to 98% and high purities. Their properties as fluorescent dyes have been investigated. Furthermore, a strategy for the hydrolysis of the BF2 group has been established using aqueous methanol and sodium hydroxide or triethylamine.
Introduction
In recent years curcumin, a pigment naturally occurring in curcuma longa, and its analogues, the curcuminoids, have attracted much attention regarding their biological activities [1]. These include antioxidant [2] and radical scavenging [3], antitumor [4] and anti-inflammatory [5] activities, as well as HIV inhibition [6]. Despite showing activity against several diseases and having only negligible side effects, low water solubility and fast degradation limit their potential medical application to this day [7].
The formation of the curcumin structure motif takes place by a base catalysed aldol condensation between the corresponding aldehyde and 2,4-pentanedione. To avoid a Knoevenagel condensation at the C-3 atom (Scheme 1a), the β-diketone moiety needs to be fixed into the enol form. In principle, this can be achieved by two different methods. The first one described by Pabon et al. utilises boric oxide in ethyl acetate as an intermediate agent (Scheme 1a) [8]. Boric acid esters like tri-n-butyl borate are normally used to scavenge water being produced during the reaction, while piperidine [9] and n-butylamine [10,11] are typical bases used as catalysts for this type of reaction (Scheme 1). Although working well with vanillin and similar derivatives, the yields strongly decrease when employing other aldehydes [12]. This procedure also requires a rather extensive work-up including several extraction steps and chromatography [8]. A second, more recent approach first published by Rao et al. relies on boron trifluoride as the complexing agent [13]. The reaction was altered by Zhang et al. to be carried out in toluene (Scheme 1b) [14]. This reaction produces the BF2 complex of the corresponding curcuminoid in yields up to 98% and high purity as an insoluble solid, which requires only a minimum of work-up.
The BF2 complexes by themselves have attracted attention regarding their properties as fluorescent dyes with fluorescence quantum yields of up to 60% and Stokes shifts of up to 5000 cm−1 [9]. Additionally, the incorporation of the BF2 group forces the β-diketone unit into the enol form, which leads to increased rigidity and enhanced photostability of the molecule [9].
Although a range of papers reports the synthesis of BF2 complexes of β-diketones such as curcuminoids [13,14] or dibenzoylmethanes [15,16], to our knowledge the reported procedures for the hydrolysis of these complexes are very limited and not always reproducible.
As part of our ongoing research to increase the selectivity of antitumor active metal complexes [17-22], our focus was on the synthesis of curcuminoids that could serve as building blocks to attach sugars like D-fructose or D-glucose [23]. Due to the easy accessibility to azido sugars [24,25] we decided to synthesise a range of curcuminoids bearing propargyl and pent-1-yn-5-yl ether groups as partners for “click” reactions [26]. We already observed that for the BF2 complex of bispropargyl functionalised bisdemethoxycurcumin, the BF2 group was hydrolysed under regular “click” reaction conditions [23].
In this paper we report on the synthesis and spectroscopic characterization of the above mentioned compound as well as seven other novel curcuminoid BF2 complexes containing terminal triple bonds in their side chains. We also optimized the reaction conditions for the cleavage of the BF2 group to release the curcuminoids as an alternative synthetic route to substituted curcumins.
Results and Discussion
Synthesis
BF2 complexes
First, we prepared the aldehydes 1a–h as the starting materials by Williamson ether synthesis of the corresponding hydroxybenzaldehydes with either propargyl bromide in dry DMF or 5-chloropent-1-yne in dry acetonitrile. As bases we used potassium carbonate for the propargyl ethers and caesium carbonate for the ethers with the longer side chains. Aqueous work-up achieved the aldehydes in excellent yields of up to 98%. NMR spectroscopic results were found to be in good accordance with the data published elsewhere [27-30].
We received the BF2 complexes 2a–h by aldol reactions between the in situ generated BF2 complex of 2,4-pentanedione and the corresponding aromatic aldehydes 1a–h. Following a procedure reported originally by Zhang [14], we were able to isolate 2a–h in yields ranging from 56 to 96% (Table 1).
Table 1: BF3·Et2O-promoted synthesis of curcuminoid–BF2 complexes 2a–h.
Entry | R1 | R2 | R3 | Yield (%) a |
2a | H | O-propargyl | OMe | 90 |
2b | H | O-propargyl | H | 96 |
2c | Br | O-propargyl | OMe | 94 |
2d | Br | O-propargyl | H | 65 |
2e | H | O-propargyl | O-propargyl | 74 |
2f | H | OMe | O-propargyl | 88 |
2g | H | OMe | O-pent-4-yn-1-yl | 56 |
2h | H | O-pent-4-yn-1-yl | H | 87 |
aYield after recrystallization.
The amount of base required have to be increased from 0.1 to ca. 0.6 equiv due to the formation of HF, which forms n-butylammonium fluoride as a main impurity. Therefore, all complexes were purified by recrystallization from a mixture of acetone and water. Because most of the compounds were partially hydrolysed when heated to 80 °C in aqueous acetone solution, we carried out the purification at room temperature. The final compounds were characterized by 1H, 11B{1H}, 13C{1H} and 19F{1H} NMR spectroscopy, EI mass spectrometry, elemental analyses as well as UV–vis absorption and fluorescence spectroscopy.
The proton NMR spectra of all compounds exhibit the characteristic AB spin systems (J = approx. 16 Hz) occurring from the trans-olefinic protons in combination with a singlet at around 6.5 ppm. Signals in 19F{1H} NMR appeared as sharp singlets at around −140 ppm, while 11B{1H} NMR signals appear as up to 3 ppm broad singlets at about +0.9 ppm. No coupling between 19F and 11B nuclei was observed because of the high quadrupole moment of the 11B nucleus. Due to the high relative mass difference between both naturally occurring boron isotopes, signals for the 10B19F and 11B19F complexes with Δδ ≈ 0.1 ppm could be found in the 19F{1H} NMR spectrum. Several additional signals were observed after a few hours, as the compounds started to hydrolyse due to residual water in DMSO-d6. Resonances at −148.6 ppm in 19F{1H} and −1.3 ppm in 11B{1H} spectra (sharp singlet) could be assigned to BF4− as the most common hydrolysis byproduct by comparison with HBF4 in DMSO-d6.
X-ray crystallography
Compounds 2f, 2g and 2h were also characterized by X-ray diffraction methods. Crystals suitable for analysis were grown by slow diffusion of n-hexane into CH2Cl2 solutions. All BF2 complexes show the expected tetrahedral coordination sphere around the boron atom and the all-trans geometry of the olefinic double bonds (Figure 1). Bond lengths and angles around the boron atom are in good accordance to values published for similar complexes [9]. One aromatic ring of 2f is twisted by approx. 8° out of the plane formed by the ligand backbone and the second aromatic ring (Figure 1a). The twisting is stabilized by an intermolecular interaction between one propargyl CH2 proton and a methoxy oxygen atom (see Supporting Information File 1 for intermolecular distances as well as selected bond length and angles). This interaction also induces the respective propargyl group to be turned by approximately 70° out of the plane formed by the backbone. Due to sterical intermolecular interactions in 2g, one pent-5-yne-1-yl chain is in gauche/anti conformation, while the other is in the more favoured anti/anti conformation (Figure 1b) with the torsion angles only slightly differing from the ideal 60° or 180°, respectively. The aromatic rings are almost coplanar with the backbone. In both cases, one of the longer side chains lays mostly within the molecule plane, while the other is turned out. The structure of complex 2h shows C2 symmetry with both side chains in gauche/anti conformation. The deviation from the ideal angles is higher than that for 2g. The plane formed by each phenyl ring is turned by approximately 5° out of the plane of the backbone.
BF2 cleavage
To hydrolyse the BF2 complexes and release the free ligands we investigated several mixtures of organic solvents and water in 4:1 ratios as well as dry THF as a control reaction at 65 °C (Table 2). Complex 2b was chosen as the model compound (Scheme 2) as 3b has been previously reported in the literature [31].
From the solvents screened, methanol and THF containing water show the best results (Table 2). Comparison with data reported in the literature [31] as well as the absence of a 19F{1H} NMR signal proved the success of the reaction. As expected, in the control reaction in dry THF no cleavage reaction was observed.
Table 2: Optimization of reaction conditions for BF2 group cleavage.
Solvent | Additive | Time (h) | Yield (%) |
---|---|---|---|
THFa | none | 18 | 75b |
MeOHa | none | 18 | 80b |
EtOHa | none | 18 | 65b |
DMFa | none | 6 | 30b |
dry THF | none | 18 | 0 |
THFa | NaOHc | 6 | 80d |
MeOH a | NaOHc | 3.5 | 98d |
aContaining 20% H2O; bYield after purification by column chromatography; c5 wt % in water; dYield after recrystallization from acetone/water.
Interestingly, upon upscaling from 0.4 mmol to 4 mmol 2b the yield of 3b decreased to approx. 40%. Alterations of reaction time and temperature resulted in no significant changes.
Rao and co-worker report, that for the BF2 complex or unsubstituted curcumin a tautomeric form exists in solution, which acts as a weak acid [13]. Only the BF2 group of the deprotonated acid is able to become hydrolysed. In our case, although no free OH groups are present, we have also observed a similar pH value dependence as reported by Rao [13]. For this reason, we suggest that the possibility to form a quinoid structure is responsible for the increased stability of the BF2 complex in acidic solution (Scheme 3). At higher temperatures, there is an equilibrium between the quinoid form of the BF2 complex with a formal negative charge on the boron atom (II, “borate”) and a structure with one cleaved boron oxygen bond having the formal negative charge localized on the oxygen atom (III, best described as a difluoroboric acid ester). The ester is prone to a nucleophilic attack of a hydroxide ion, while the borate is not. After the nucleophilic attack a hydroxy difluoroborate (IV) is formed, which undergoes fast hydrolysis to boric acid, hydrogen fluoride and the corresponding curcuminoid in the anionic form (V). The latter finally becomes protonated by one equivalent of HF (VI). If no additional base is present, the hydroxide concentration decreases with ongoing hydrolysis so far, that the reaction effectively stops.
To confirm our suggestion we carried out the hydrolysis reactions of 4 mmol 2b in 80% aq methanol or THF again with the addition of 10 mol % of NaOH. The final yields could be increased to 98 and 80%, respectively. Additionally, we could observe a much shorter reaction time. This proves the necessity for a base to be present to complete the reaction.
We were able to apply this procedure to BF2 complexes 2a–c and 2e to receive the curcuminoids 3 in good to excellent yields. 2d and 2f–h were found to possess a relatively low solubility in methanol and especially 2d to be more sensitive to nucleophilic bases when heated in solution. To increase the solubility, most of the water added was replaced by DMSO (Table 3). This improved the solubility and did not induce any additional impurities. We also changed the base from NaOH to triethylamine for these compounds to avoid partial decomposition. The disadvantage of triethylamine was a longer reaction time of seven to eighteen hours, probably due to the lower hydroxide concentration.
Table 3: Hydrolysis reactions.
Entry | R1 | R2 | R3 | Solvent (MeOH/DMSO/H2O) | Base | Yield (%)a |
3a | H | O-propargyl | OMe | 8:0:2 | NaOHb | 87 |
3b | H | O-propargyl | H | 8:0:2 | NaOH | 92 |
3c | Br | O-propargyl | OMe | 8:0:2 | NaOH | 92 |
3d | Br | O-propargyl | H | 8:1.5:0.5 | TEA | n/a |
3e | H | O-propargyl | O-propargyl | 8:0:2 | NaOH | 84 |
3f | H | OMe | O-propargyl | 8:1.5:0.5 | TEA | 90 |
3g | H | OMe | O-pent-4-yn-1-yl | 8:1.5:0.5 | TEA | 80 |
3h | H | O-pent-4-yn-1-yl | H | 8:1.5:0.5 | TEA | 95 |
aYield after recrystallization; b5 wt % solution in water.
Regarding the 1H NMR spectra, we found that all crude products contain small amounts of decomposition products resulting from base induced cleavage of the backbone. Recrystallization from acetone or ethanol and water mixtures gave the pure products 3a–c and 3e–h as yellow or orange solids in good to excellent yields. They were characterized by 1H and 13C{1H} NMR spectroscopy, mass spectrometry, UV-visible spectroscopy and elemental analysis. For 3d we found two sets of NMR signals in both 1H and 13C{1H} NMR spectra with relative intensities of 1:0.25, which could be assigned to be no starting material. These did not change upon alteration of NMR solvent or temperature. Also, no [M]+ signals or any expected fragments for 3d were found in EI or ESIMS spectra.
Optical spectroscopy
To investigate their properties as fluorescent dyes we measured the UV–vis absorption and fluorescence spectra of the BF2 complexes 2a–h. Measurements were carried out in dichloromethane at room temperature and under ambient atmosphere. The results are shown in Figure 2.
All BF2 complexes show strong absorption bands with absorption maxima between 475 and 503 nm resulting from π–π* transitions [9]. Extinction coefficients range from roughly 9500 to over 50000 M−1 cm−1 (Table 4). All absorption curves show secondary maxima or shoulders at slightly shorter wavelengths.
Table 4: Absorption and emission spectral properties of BF2 complexes 2a–h in CH2Cl2. See Supporting Information File 1 for details on the measurement setup.
Compound | λmaxabs (nm) | ε · 10-3 (M−1 cm−1) | λmaxem (nm) | Φa | τb (ns) | Stokes-shift (cm−1) |
2a | 497 | 41.0 | 548 | 0.51 | 1.68 | 1873 |
2b | 480 | 10.1 | 528 | 0.29 | 1.21 | 1894 |
2c | 476 | 48.5 | 522 | 0.27 | 1.01 | 1851 |
2d | 475 | 19.8 | 524 | 0.25 | 1.01 | 1969 |
2e | 487 | 30.0 | 547 | 0.38 | 1.56 | 2252 |
2f | 497 | 52.8 | 550 | 0.49 | 1.55 | 1939 |
2g | 503 | 18.2 | 590 | 0.34 | 1.57 | 2932 |
2h | 489 | 9.5 | 542 | 0.18 | 1.50 | 2000 |
aFluorescence quantum yield was determined against rhodamine 6G (Φ = 0.95) in ethanol. bFluorescence lifetime upon 400 nm excitation.
As solvatochromism is a known property for curcumin and its derivatives [32,33], we investigated the solvatochromism of 2b as an example compound in five different solvents (Figure 3). Solvents were chosen by their ET(30) values of polarity as determined by Reichardt [34]. With rising solvent polarity, the vibrational structure of the absorption band is being lost. In toluene, THF and dichloromethane the compound shows only weak solvatochromism. Interestingly, a positive solvatochromism relative to the more nonpolar solvents is appearing in DMSO, while the absorption band is slightly being shifted hypsochromically in methanol.
In solution, upon excitation at 365 nm, green, yellow or orange fluorescence can be observed (Figure 4).
All fluorescence spectra are characterized by two maxima, one in the range of 520–550 nm and one in the range of 580–590 nm. However, there are distinct differences in the intensity ratios of these two maxima between the compounds. For 2b–d, the lower energy maximum appears as a shoulder, for 2a and 2e–h, it appears as a local maximum, and for 2g it represents the global maximum of emission. This trend can be rationalized by taking the electronic structure of the compounds into account. With increasing electron density of the aromatic system, the emission intensity in the low-energy regime of the spectrum increases. It is also noteworthy, that regarding 2a and 2f, which are regioisomers, the second fluorescence band is more intense for 2f than for 2a. For the complexes containing a brominated phenyl ring, the presence of an additional electron-donating methoxy group has almost no impact on the fluorescence properties.
Conclusion
We have synthesized a series of novel curcuminoid–BF2 complexes by an improved synthetic route. All complexes were received in high yields and purities and characterized by 1H, 11B, 13C and 19F NMR spectroscopy, mass spectrometry and elemental analysis. We found the complexes to possess high absorption in the range of 475 to 500 nm and strong fluorescence between 520 and 590 nm, resulting in Stokes shifts of up to 3000 cm−1. Finally, an effective strategy to hydrolyse the BF2 group and release the curcuminoids could be established using aqueous methanol and mild basic conditions. In some cases, when the solubility of the substrates was low, DMSO was used as an additional solvent. These compounds can act as building blocks for the attachment of biomolecules via “click” chemistry.
Supporting Information
Supporting Information File 1: Experimental data, X-ray crystallographic details, selected bond lengths and angles, copies of NMR spectra. | ||
Format: PDF | Size: 3.0 MB | Download |
Supporting Information File 2: CIF files for complexes 2f, 2g and 2h. These data (CCDC-1526555 for 2f, CCDC-1526556 for 2g, and CCDC-1526557 for 2h) can be obtained free of charge from The Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif. | ||
Format: CIF | Size: 50.0 KB | Download |
References
-
Esatbeyoglu, T.; Huebbe, P.; Ernst, I. M. A.; Chin, D.; Wagner, A. E.; Rimbach, G. Angew. Chem., Int. Ed. 2012, 51, 5308–5332. doi:10.1002/anie.201107724
Return to citation in text: [1] -
Tønnesen, H. H.; Greenhill, J. V. Int. J. Pharm. 1992, 87, 79–87. doi:10.1016/0378-5173(92)90230-Y
Return to citation in text: [1] -
Anto, R.; Kuttan, G.; Babu, K. V. D.; Rajasekharan, K. N.; Kuttan, R. Int. J. Pharm. 1996, 131, 1–7. doi:10.1016/0378-5173(95)04254-7
Return to citation in text: [1] -
Kuttan, R.; Bhanumathy, P.; Nirmala, K.; George, M. C. Cancer Lett. 1985, 29, 197–202. doi:10.1016/0304-3835(85)90159-4
Return to citation in text: [1] -
Ghosh, S.; Hayden, M. S. Nat. Rev. Immunol. 2008, 8, 837–848. doi:10.1038/nri2423
Return to citation in text: [1] -
Artico, M.; Di Santo, R.; Costi, R.; Novellino, E.; Greco, G.; Massa, S.; Tramontano, E.; Marongiu, M. E.; De Montis, A.; La Colla, P. J. Med. Chem. 1998, 41, 3948–3960. doi:10.1021/jm9707232
Return to citation in text: [1] -
Ammon, H. P. T.; Wahl, M. A. Planta Med. 1991, 57, 1–7. doi:10.1055/s-2006-960004
Return to citation in text: [1] -
Pabon, H. J. J. Recl. Trav. Chim. Pays-Bas 1964, 83, 379–386. doi:10.1002/recl.19640830407
Return to citation in text: [1] [2] -
Bai, G.; Yu, C.; Cheng, C.; Hao, E.; Wei, Y.; Mu, X.; Jiao, L. Org. Biomol. Chem. 2014, 12, 1618–1626. doi:10.1039/c3ob42201a
Return to citation in text: [1] [2] [3] [4] [5] -
Pedersen, U.; Rasmussen, P. B.; Lawesson, S.-O. Liebigs Ann. Chem. 1985, 1557–1569. doi:10.1002/jlac.198519850805
Return to citation in text: [1] -
Nurfina, A. N.; Reksohadiprodjo, M. S.; Timmerman, H.; Jenie, U. A.; Sugiyanto, D.; van der Goot, H. Eur. J. Med. Chem. 1997, 32, 321–328. doi:10.1016/S0223-5234(97)89084-8
Return to citation in text: [1] -
Khan, M. A.; El-Khatib, R.; Rainsford, K. D.; Whitehouse, M. W. Bioorg. Chem. 2012, 40, 30–38. doi:10.1016/j.bioorg.2011.11.004
Return to citation in text: [1] -
Rao, E. V.; Sudheer, P. Indian J. Pharm. Sci. 2011, 73, 262–270.
Return to citation in text: [1] [2] [3] [4] -
Liu, K.; Chen, J.; Chojnacki, J.; Zhang, S. Tetrahedron Lett. 2013, 54, 2070–2073. doi:10.1016/j.tetlet.2013.02.015
Return to citation in text: [1] [2] [3] -
Ono, K.; Yoshikawa, K.; Tsuji, Y.; Yamaguchi, H.; Uozumi, R.; Tomura, M.; Taga, K.; Saito, K. Tetrahedron 2007, 63, 9354–9358. doi:10.1016/j.tet.2007.07.004
Return to citation in text: [1] -
Hu, J.; He, Z.; Wang, Z.; Li, X.; You, J.; Gao, G. Tetrahedron Lett. 2013, 54, 4167–4170. doi:10.1016/j.tetlet.2013.05.099
Return to citation in text: [1] -
Mügge, C.; Marzo, T.; Massai, L.; Hildebrandt, J.; Ferraro, G.; Rivera-Fuentes, P.; Metzler-Nolte, N.; Merlino, A.; Messori, L.; Weigand, W. Inorg. Chem. 2015, 54, 8560–8570. doi:10.1021/acs.inorgchem.5b01238
Return to citation in text: [1] -
Mügge, C.; Liu, R.; Görls, H.; Gabbiani, C.; Michelucci, E.; Rüdiger, N.; Clement, J. H.; Messori, L.; Weigand, W. Dalton Trans. 2014, 43, 3072–3086. doi:10.1039/c3dt52284a
Return to citation in text: [1] -
Mügge, C.; Micheucci, E.; Boscaro, F.; Gabbiani, C.; Messori, L.; Weigand, W. Metallomics 2011, 3, 987–990. doi:10.1039/c1mt00069a
Return to citation in text: [1] -
Mügge, C.; Rothenburger, C.; Beyer, A.; Görls, H.; Gabbiani, C.; Casini, A.; Michelucci, E.; Landini, I.; Nobili, S.; Mini, E.; Messori, L.; Weigand, W. Dalton Trans. 2011, 40, 2006–2016. doi:10.1039/c0dt00845a
Return to citation in text: [1] -
Hildebrandt, J.; Häfner, N.; Görls, H.; Kritsch, D.; Ferraro, G.; Dürst, M.; Runnebaum, I. B.; Merlino, A.; Weigand, W. Dalton Trans. 2016, 45, 18876–18891. doi:10.1039/c6dt01388k
Return to citation in text: [1] -
Hildebrandt, J.; Görls, H.; Häfner, N.; Ferraro, G.; Dürst, M.; Runnebaum, I. B.; Weigand, W.; Merlino, A. Dalton Trans. 2016, 45, 12283–12287. doi:10.1039/c6dt02380k
Return to citation in text: [1] -
Pröhl, M.; Bus, T.; Czaplewska, J. A.; Traeger, A.; Deicke, M.; Weiss, H.; Weigand, W.; Schubert, U. S.; Gottschaldt, M. Eur. J. Inorg. Chem. 2016, 5197–5204. doi:10.1002/ejic.201600801
Return to citation in text: [1] [2] -
Kieburg, C.; Sadalapure, K.; Lindhorst, T. K. Eur. J. Org. Chem. 2000, 2035–2040. doi:10.1002/1099-0690(200006)2000:11<2035::AID-EJOC2035>3.0.CO;2-V
Return to citation in text: [1] -
Maryanoff, B. E.; McComsey, D. F.; Costanzo, M. J.; Hochman, C.; Smith-Swintosky, V.; Shank, R. P. J. Med. Chem. 2005, 48, 1941–1947. doi:10.1021/jm040124c
Return to citation in text: [1] -
Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41, 2596–2599. doi:10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
Return to citation in text: [1] -
Pal, M.; Parasuraman, K.; Yeleswarapu, K. R. Org. Lett. 2003, 5, 349–352. doi:10.1021/ol027382t
Return to citation in text: [1] -
Kant, R.; Kumar, D.; Agarwal, D.; Gupta, R. D.; Tilak, R.; Awasthi, S. K.; Agarwal, A. Eur. J. Med. Chem. 2016, 113, 34–49. doi:10.1016/j.ejmech.2016.02.041
Return to citation in text: [1] -
Zammit, S. C.; Cox, A. J.; Gow, R. M.; Zhang, Y.; Gilbert, R. E.; Krum, H.; Kelly, D. J.; Williams, S. J. Bioorg. Med. Chem. Lett. 2009, 19, 7003–7006. doi:10.1016/j.bmcl.2009.09.120
Return to citation in text: [1] -
Goto, H.; Nimori, S.; Akagi, K. Synth. Met. 2005, 155, 576–587. doi:10.1016/j.synthmet.2005.09.044
Return to citation in text: [1] -
Gomes, D. de C. F.; Alegrio, L. V.; Edilson Freire de Lim, M.; Leon, L. L.; Araújo, C. A. C. Arzneim. Forsch. 2002, 52, 120–124. doi:10.1055/s-0031-1299867
Return to citation in text: [1] [2] -
Khopde, S. M.; Priyadarsini, K. I.; Palit, D. K.; Mukherjee, T. Photochem. Photobiol. 2000, 72, 625–631. doi:10.1562/0031-8655(2000)0720625EOSOTE2.0.CO2
Return to citation in text: [1] -
Barik, A.; Priyadarsini, K. I. Spectrochim. Acta, Part A 2013, 105, 267–272. doi:10.1016/j.saa.2012.12.036
Return to citation in text: [1] -
Reichardt, C. Chem. Rev. 1994, 94, 2319–2358. doi:10.1021/cr00032a005
Return to citation in text: [1]
31. | Gomes, D. de C. F.; Alegrio, L. V.; Edilson Freire de Lim, M.; Leon, L. L.; Araújo, C. A. C. Arzneim. Forsch. 2002, 52, 120–124. doi:10.1055/s-0031-1299867 |
1. | Esatbeyoglu, T.; Huebbe, P.; Ernst, I. M. A.; Chin, D.; Wagner, A. E.; Rimbach, G. Angew. Chem., Int. Ed. 2012, 51, 5308–5332. doi:10.1002/anie.201107724 |
5. | Ghosh, S.; Hayden, M. S. Nat. Rev. Immunol. 2008, 8, 837–848. doi:10.1038/nri2423 |
9. | Bai, G.; Yu, C.; Cheng, C.; Hao, E.; Wei, Y.; Mu, X.; Jiao, L. Org. Biomol. Chem. 2014, 12, 1618–1626. doi:10.1039/c3ob42201a |
4. | Kuttan, R.; Bhanumathy, P.; Nirmala, K.; George, M. C. Cancer Lett. 1985, 29, 197–202. doi:10.1016/0304-3835(85)90159-4 |
9. | Bai, G.; Yu, C.; Cheng, C.; Hao, E.; Wei, Y.; Mu, X.; Jiao, L. Org. Biomol. Chem. 2014, 12, 1618–1626. doi:10.1039/c3ob42201a |
3. | Anto, R.; Kuttan, G.; Babu, K. V. D.; Rajasekharan, K. N.; Kuttan, R. Int. J. Pharm. 1996, 131, 1–7. doi:10.1016/0378-5173(95)04254-7 |
2. | Tønnesen, H. H.; Greenhill, J. V. Int. J. Pharm. 1992, 87, 79–87. doi:10.1016/0378-5173(92)90230-Y |
14. | Liu, K.; Chen, J.; Chojnacki, J.; Zhang, S. Tetrahedron Lett. 2013, 54, 2070–2073. doi:10.1016/j.tetlet.2013.02.015 |
9. | Bai, G.; Yu, C.; Cheng, C.; Hao, E.; Wei, Y.; Mu, X.; Jiao, L. Org. Biomol. Chem. 2014, 12, 1618–1626. doi:10.1039/c3ob42201a |
12. | Khan, M. A.; El-Khatib, R.; Rainsford, K. D.; Whitehouse, M. W. Bioorg. Chem. 2012, 40, 30–38. doi:10.1016/j.bioorg.2011.11.004 |
8. | Pabon, H. J. J. Recl. Trav. Chim. Pays-Bas 1964, 83, 379–386. doi:10.1002/recl.19640830407 |
8. | Pabon, H. J. J. Recl. Trav. Chim. Pays-Bas 1964, 83, 379–386. doi:10.1002/recl.19640830407 |
7. | Ammon, H. P. T.; Wahl, M. A. Planta Med. 1991, 57, 1–7. doi:10.1055/s-2006-960004 |
9. | Bai, G.; Yu, C.; Cheng, C.; Hao, E.; Wei, Y.; Mu, X.; Jiao, L. Org. Biomol. Chem. 2014, 12, 1618–1626. doi:10.1039/c3ob42201a |
6. | Artico, M.; Di Santo, R.; Costi, R.; Novellino, E.; Greco, G.; Massa, S.; Tramontano, E.; Marongiu, M. E.; De Montis, A.; La Colla, P. J. Med. Chem. 1998, 41, 3948–3960. doi:10.1021/jm9707232 |
10. | Pedersen, U.; Rasmussen, P. B.; Lawesson, S.-O. Liebigs Ann. Chem. 1985, 1557–1569. doi:10.1002/jlac.198519850805 |
11. | Nurfina, A. N.; Reksohadiprodjo, M. S.; Timmerman, H.; Jenie, U. A.; Sugiyanto, D.; van der Goot, H. Eur. J. Med. Chem. 1997, 32, 321–328. doi:10.1016/S0223-5234(97)89084-8 |
32. | Khopde, S. M.; Priyadarsini, K. I.; Palit, D. K.; Mukherjee, T. Photochem. Photobiol. 2000, 72, 625–631. doi:10.1562/0031-8655(2000)0720625EOSOTE2.0.CO2 |
33. | Barik, A.; Priyadarsini, K. I. Spectrochim. Acta, Part A 2013, 105, 267–272. doi:10.1016/j.saa.2012.12.036 |
17. | Mügge, C.; Marzo, T.; Massai, L.; Hildebrandt, J.; Ferraro, G.; Rivera-Fuentes, P.; Metzler-Nolte, N.; Merlino, A.; Messori, L.; Weigand, W. Inorg. Chem. 2015, 54, 8560–8570. doi:10.1021/acs.inorgchem.5b01238 |
18. | Mügge, C.; Liu, R.; Görls, H.; Gabbiani, C.; Michelucci, E.; Rüdiger, N.; Clement, J. H.; Messori, L.; Weigand, W. Dalton Trans. 2014, 43, 3072–3086. doi:10.1039/c3dt52284a |
19. | Mügge, C.; Micheucci, E.; Boscaro, F.; Gabbiani, C.; Messori, L.; Weigand, W. Metallomics 2011, 3, 987–990. doi:10.1039/c1mt00069a |
20. | Mügge, C.; Rothenburger, C.; Beyer, A.; Görls, H.; Gabbiani, C.; Casini, A.; Michelucci, E.; Landini, I.; Nobili, S.; Mini, E.; Messori, L.; Weigand, W. Dalton Trans. 2011, 40, 2006–2016. doi:10.1039/c0dt00845a |
21. | Hildebrandt, J.; Häfner, N.; Görls, H.; Kritsch, D.; Ferraro, G.; Dürst, M.; Runnebaum, I. B.; Merlino, A.; Weigand, W. Dalton Trans. 2016, 45, 18876–18891. doi:10.1039/c6dt01388k |
22. | Hildebrandt, J.; Görls, H.; Häfner, N.; Ferraro, G.; Dürst, M.; Runnebaum, I. B.; Weigand, W.; Merlino, A. Dalton Trans. 2016, 45, 12283–12287. doi:10.1039/c6dt02380k |
13. | Rao, E. V.; Sudheer, P. Indian J. Pharm. Sci. 2011, 73, 262–270. |
14. | Liu, K.; Chen, J.; Chojnacki, J.; Zhang, S. Tetrahedron Lett. 2013, 54, 2070–2073. doi:10.1016/j.tetlet.2013.02.015 |
15. | Ono, K.; Yoshikawa, K.; Tsuji, Y.; Yamaguchi, H.; Uozumi, R.; Tomura, M.; Taga, K.; Saito, K. Tetrahedron 2007, 63, 9354–9358. doi:10.1016/j.tet.2007.07.004 |
16. | Hu, J.; He, Z.; Wang, Z.; Li, X.; You, J.; Gao, G. Tetrahedron Lett. 2013, 54, 4167–4170. doi:10.1016/j.tetlet.2013.05.099 |
9. | Bai, G.; Yu, C.; Cheng, C.; Hao, E.; Wei, Y.; Mu, X.; Jiao, L. Org. Biomol. Chem. 2014, 12, 1618–1626. doi:10.1039/c3ob42201a |
31. | Gomes, D. de C. F.; Alegrio, L. V.; Edilson Freire de Lim, M.; Leon, L. L.; Araújo, C. A. C. Arzneim. Forsch. 2002, 52, 120–124. doi:10.1055/s-0031-1299867 |
27. | Pal, M.; Parasuraman, K.; Yeleswarapu, K. R. Org. Lett. 2003, 5, 349–352. doi:10.1021/ol027382t |
28. | Kant, R.; Kumar, D.; Agarwal, D.; Gupta, R. D.; Tilak, R.; Awasthi, S. K.; Agarwal, A. Eur. J. Med. Chem. 2016, 113, 34–49. doi:10.1016/j.ejmech.2016.02.041 |
29. | Zammit, S. C.; Cox, A. J.; Gow, R. M.; Zhang, Y.; Gilbert, R. E.; Krum, H.; Kelly, D. J.; Williams, S. J. Bioorg. Med. Chem. Lett. 2009, 19, 7003–7006. doi:10.1016/j.bmcl.2009.09.120 |
30. | Goto, H.; Nimori, S.; Akagi, K. Synth. Met. 2005, 155, 576–587. doi:10.1016/j.synthmet.2005.09.044 |
14. | Liu, K.; Chen, J.; Chojnacki, J.; Zhang, S. Tetrahedron Lett. 2013, 54, 2070–2073. doi:10.1016/j.tetlet.2013.02.015 |
26. | Rostovtsev, V. V.; Green, L. G.; Fokin, V. V.; Sharpless, K. B. Angew. Chem., Int. Ed. 2002, 41, 2596–2599. doi:10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4 |
23. | Pröhl, M.; Bus, T.; Czaplewska, J. A.; Traeger, A.; Deicke, M.; Weiss, H.; Weigand, W.; Schubert, U. S.; Gottschaldt, M. Eur. J. Inorg. Chem. 2016, 5197–5204. doi:10.1002/ejic.201600801 |
23. | Pröhl, M.; Bus, T.; Czaplewska, J. A.; Traeger, A.; Deicke, M.; Weiss, H.; Weigand, W.; Schubert, U. S.; Gottschaldt, M. Eur. J. Inorg. Chem. 2016, 5197–5204. doi:10.1002/ejic.201600801 |
24. | Kieburg, C.; Sadalapure, K.; Lindhorst, T. K. Eur. J. Org. Chem. 2000, 2035–2040. doi:10.1002/1099-0690(200006)2000:11<2035::AID-EJOC2035>3.0.CO;2-V |
25. | Maryanoff, B. E.; McComsey, D. F.; Costanzo, M. J.; Hochman, C.; Smith-Swintosky, V.; Shank, R. P. J. Med. Chem. 2005, 48, 1941–1947. doi:10.1021/jm040124c |
© 2017 Weiss et al.; licensee Beilstein-Institut.
This is an Open Access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The license is subject to the Beilstein Journal of Organic Chemistry terms and conditions: (http://www.beilstein-journals.org/bjoc)